APP and Alzheimer disease: In this regard, modulating ribosome-mediated QC to get rid of aberrant APP.C99 RQC products, or restoring endolysosomal and autophagy function impaired by aberrant APP.C99 deserve serious consideration, as such manipulations rescued AD-related synapse and network dysfunction and behavioral outcomes in our AD model studies.